Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
So Young Park, Hyun Sik Gong, Kyoung Min Kim, Dam Kim, Ha Young Kim, Chan Hong Jeon, Ji Hyeon Ju, Shin-Seok Lee, Dong-Ah Park, Yoon-Kyoung Sung, Sang Wan Kim
J Bone Metab. 2018;25(4):195-211.   Published online 2018 Nov 30     DOI: https://doi.org/10.11005/jbm.2018.25.4.195
Citations to this article as recorded by Crossref logo
Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study
So Young Park, Seong Hee Ahn, Gi Hwan Bae, Sunmee Jang, Mi Kyung Kwak, Ha Young Kim, Se Hwa Kim
Osteoporosis International.2024; 35(10): 1779.     CrossRef
Ukrainian guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis
N.V. Grygorieva, V.M. Kovalenko, М.О. Коrzh, M.D. Tronko, I.Yu. Golovach, N.V. Dedukh, D.G. Rekalov, S.S. Strafun, S.I. Smiyan, O.A. Golubovska, Ya.O. Dziublyk, N.V. Kharchenko, G.O. Protsenko, O.O. Garmish, V.L. Orlenko, F.V. Klymovytsky, А.S. Musiіenko,
PAIN, JOINTS, SPINE.2024; 14(3): 1.     CrossRef
Comparison of predictive value of FRAX, trabecular bone score, and bone mineral density for vertebral fractures in systemic sclerosis: A cross-sectional study
Kyung-Ann Lee, Hyun-Joo Kim, Hyun-Sook Kim
Medicine.2023; 102(2): e32580.     CrossRef
Treatment of Autoimmune Hepatitis
Ja Kyung Kim
The Korean Journal of Gastroenterology.2023; 81(2): 72.     CrossRef
KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Clinical and Molecular Hepatology.2023; 29(3): 542.     CrossRef
AUTOIMMUNE HEPATITIS AND THE COMPLEXITY OF ITS MANAGEMENT: A CLINICAL CASE
V. N. Zhdan, O. A. Kyrian, M. Yu. Babanina, I. V. Ivanytskyi, M. V. Tkachenko, V. G. Lebid
Bulletin of Problems Biology and Medicine.2023; 1(2): 179.     CrossRef
Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study
M. Iki, K. Fujimori, S. Nakatoh, J. Tamaki, S. Ishii, N. Okimoto, K. Kamiya, S. Ogawa
Osteoporosis International.2022; 33(5): 1097.     CrossRef
The Korean College of Rheumatology: 40 Years of Public Health Influence
Jisoo Lee, Yoon-Kyoung Sung, Myeung-Su Lee, Han Joo Baek
Journal of Rheumatic Diseases.2022; 29(2): 75.     CrossRef
Fracture risk associated with glucocorticoid-induced osteoporosis in Japan
Satoshi Soen, Miki Kaku, Naoki Okubo, Yoshie Onishi, Kengo Saito, Makiko Kobayashi
Journal of Bone and Mineral Metabolism.2022; 40(4): 636.     CrossRef
Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis
Filippo Migliorini, Giorgia Colarossi, Jörg Eschweiler, Francesco Oliva, Arne Driessen, Nicola Maffulli
British Medical Bulletin.2022; 143(1): 46.     CrossRef
Clivus-involved immunoglobulin G4 related hypertrophic pachymeningitis mimicking meningioma: A case report
Yang Yu, Liang Lv, Sen-Lin Yin, Cheng Chen, Shu Jiang, Pei-Zhi Zhou
World Journal of Clinical Cases.2022; 10(18): 6269.     CrossRef
Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update
Osvaldo Daniel Messina, Maritza Vidal, Jorge A Morales Torres, Luis Fernando Vidal, Constanza Arguissain, Rosa María Pereira, Patricia Clark, Sonia Cerdas Perez, Claudia Campusano, Marise Lazaretti-Castro, Cristiano Zerbini, Juan J. Scali, Lucia Mendez Sa
Aging Clinical and Experimental Research.2022; 34(11): 2591.     CrossRef
Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review
A.M. Burden, Y. Tanaka, L. Xu, Y.-C. Ha, E. McCloskey, S.R. Cummings, C.C. Glüer
Osteoporosis International.2021; 32(5): 817.     CrossRef
Therapies for Preventing Bone Loss with Glucocorticoid Treatment
Arnav Agarwal, Jonathan D. Adachi
Current Osteoporosis Reports.2021; 19(1): 34.     CrossRef
Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis
X. Huang, B. Chen, L. Thabane, J.D. Adachi, G. Li
Osteoporosis International.2021; 32(9): 1713.     CrossRef
Quality assessment of traditional and conventional medicine clinical practice guidelines for osteoporosis
Jung-Hyun Kim, Byung-Kwan Seo, Yong-Hyeon Baek
Medicine.2021; 100(5): e24559.     CrossRef
Epidemiology of glucocorticoid-induced osteoporosis and management of associated fracture risk in Japan
Satoshi Soen, Miki Kaku, Naoki Okubo, Salsabil Touzeni, Kengo Saito, Makiko Kobayashi
Journal of Bone and Mineral Metabolism.2021; 39(6): 1019.     CrossRef
Update on Glucocorticoid Induced Osteoporosis
Soo-Kyung Cho, Yoon-Kyoung Sung
Endocrinology and Metabolism.2021; 36(3): 536.     CrossRef
Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long‐term and low‐dose glucocorticoid
Kyung‐Ann Lee, JongSun Kim, Hyun‐joo Kim, Hyun‐Sook Kim
International Journal of Rheumatic Diseases.2021; 24(8): 1053.     CrossRef
Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Management der Glukokortikoid-induzierten Osteoporose
Jan Leipe, Julia U. Holle, Christiane Weseloh, Alexander Pfeil, Klaus Krüger
Zeitschrift für Rheumatologie.2021; 80(7): 670.     CrossRef
Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study
Bora Nam, Yoon-Kyoung Sung, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Sang-Cheol Bae, Dae-Hyun Yoo, Soo-Kyung Cho
Journal of Korean Medical Science.2021;[Epub]     CrossRef
German Society of Rheumatology recommendations for management of glucocorticoid-induced osteoporosis
Jan Leipe, Julia U. Holle, Christiane Weseloh, Alexander Pfeil, Klaus Krüger
Zeitschrift für Rheumatologie.2021; 80(S2): 49.     CrossRef
Management of Osteoporosis in Liver Transplant Recipients
Hojeong Choi, Boram Kim, Yoonhee Kim, Jungwha Lee, Eunsook Lee, Euni Lee, Jai Young Cho, YoungRok Choi
Korean Journal of Clinical Pharmacy.2020; 30(1): 51.     CrossRef
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Pojchong Chotiyarnwong, Eugene V. McCloskey
Nature Reviews Endocrinology.2020; 16(8): 437.     CrossRef
Glucocorticoid-induced osteoporosis: pathogenesis and prevention
I. G. Krasivina, L. N. Dolgova, N. V. Dolgov, A. A. Larina
Medical Council.2020; (21): 126.     CrossRef
Vitamin D supplementation does not prevent the recurrence of Graves’ disease
Yoon Young Cho, Yun Jae Chung
Scientific Reports.2020;[Epub]     CrossRef
Bone Mineral Density in Diabetes Mellitus Foot Patients for Prediction of Diabetic Neuropathic Osteoarthropathic Fracture
Jae-Ho Cho, Tae-Hong Min, Dong-Il Chun, Sung-Hun Won, Su Yeon Park, Kwonwoo Kim, Young Yi
Journal of Bone Metabolism.2020; 27(3): 207.     CrossRef
Physicians’ Attitudes on Management of Osteopenia in South Korea
Joo Hyung Ha, Hong Seok Kim, Samuel Jaeyoon Won, Young-Kyun Lee, Kyung-Hoi Koo
Journal of Bone Metabolism.2020; 27(3): 201.     CrossRef
Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines
Tae-Han Lee, Yeo-Jin Song, Hyoungyoung Kim, Yoon-Kyoung Sung, Soo-Kyung Cho
Journal of Bone Metabolism.2020; 27(4): 247.     CrossRef
Effect of glucocorticoids on bone metabolism in replacement therapy of adrenal insufficiency. Literature review
M. Yu. Yukina, M. O. Chernova, N. F. Nuralieva, A. K. Eremkina, E. A. Troshina, G. A. Melnichenko, N. G. Mokrysheva
Obesity and metabolism.2020; 17(4): 357.     CrossRef
Evaluation of the effect of CaD on the bone structure and bone metabolic changes in senile osteoporosis rats based on MLP–ANN methods
Xiufeng Tang, Yingying Gao, Yuheng Chen, Xiaoxi Li, Ping Yu, Zitong Ma, Renhui Liu
Food & Function.2019; 10(12): 8026.     CrossRef
Treatment of Glucocorticoid-Induced Osteoporosis with Bisphosphonates Alone, Vitamin D Alone or a Combination Treatment in Eastern Asians: A Meta-Analysis
Junjie Wang, Hongzhuo Li
Current Pharmaceutical Design.2019; 25(14): 1653.     CrossRef